These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18166912)

  • 1. [Methotrexate].
    Richard MA; Guillaume JC
    Ann Dermatol Venereol; 2007 Dec; 134(12):923-6. PubMed ID: 18166912
    [No Abstract]   [Full Text] [Related]  

  • 2. Methotrexate: role of treatment in skin disease.
    Holliday AC; Moody MN; Berlingeri-Ramos A
    Skin Therapy Lett; 2013; 18(3):4-9. PubMed ID: 23674145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mood changes with methotrexate therapy for dermatologic disease.
    Bhat T; Coughlin CC
    Pediatr Dermatol; 2018 Mar; 35(2):253-254. PubMed ID: 29315793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate: practical use in dermatology.
    Diani M; Grasso V; Altomare G
    G Ital Dermatol Venereol; 2016 Oct; 151(5):535-43. PubMed ID: 26761767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of methotrexate in dermatology: a review.
    Shen S; O'Brien T; Yap LM; Prince HM; McCormack CJ
    Australas J Dermatol; 2012 Feb; 53(1):1-18. PubMed ID: 22309324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expanding role of methotrexate for treating skin disease.
    Chalmers RJ
    Br J Dermatol; 2016 Jul; 175(1):9-10. PubMed ID: 27484263
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of methotrexate in pediatric dermatology].
    Mazereeuw-Hautier J; Uthurriague C
    Ann Dermatol Venereol; 2016 Feb; 143(2):154-61. PubMed ID: 26724843
    [No Abstract]   [Full Text] [Related]  

  • 8. [Methotrexate in dermatology: pharmacology, indications, applications and prudent use].
    Lebrun-Vignes B; Bachelez H; Chosidow O
    Rev Med Interne; 1999 Aug; 20 Suppl 3():384s-392s. PubMed ID: 10480190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H-like syndrome successfully treated with methotrexate.
    Zaouak A; Jaouadi H; Chamli A; Jouini R; Abdelhak S; Hammami H; Fenniche S
    Dermatol Ther; 2019 Jul; 32(4):e12994. PubMed ID: 31197883
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombocytopenia after a single test dose of methotrexate.
    Jih DM; Werth VP
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):349-51. PubMed ID: 9703150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate.
    Steen AE; Steen KH; Bauer R; Bieber T
    Br J Dermatol; 2001 Jul; 145(1):137-40. PubMed ID: 11453923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Koebner Phenomenon in Dermatomyositis after Subcutaneous Methotrexate Injections.
    Couture P; Bachmeyer C; Monfort JB
    J Rheumatol; 2019 Oct; 46(10):1350. PubMed ID: 31575735
    [No Abstract]   [Full Text] [Related]  

  • 13. [Eventration and methotrexate in psoriasis].
    Schmutz JL; Barbaud A; Trechot P
    Ann Dermatol Venereol; 2010 Oct; 137(10):672. PubMed ID: 20932456
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate in psoriasis: consensus conference.
    Roenigk HH; Auerbach R; Maibach H; Weinstein G; Lebwohl M
    J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
    [No Abstract]   [Full Text] [Related]  

  • 15. British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.
    Warren RB; Weatherhead SC; Smith CH; Exton LS; Mohd Mustapa MF; Kirby B; Yesudian PD
    Br J Dermatol; 2016 Jul; 175(1):23-44. PubMed ID: 27484275
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate.
    Boffa MJ
    Adv Exp Med Biol; 1999; 455():341-2. PubMed ID: 10599367
    [No Abstract]   [Full Text] [Related]  

  • 17. Yellow nail pigmentation due to methotrexate.
    Malka N; Reichert S; Trechot P; Barbaud A; Schmutz JL
    Dermatology; 1998; 197(3):276. PubMed ID: 9867364
    [No Abstract]   [Full Text] [Related]  

  • 18. Alcohol interactions with drugs and its effect on the treatment of skin diseases.
    Zachariae H
    Clin Dermatol; 1999; 17(4):443-5. PubMed ID: 10497730
    [No Abstract]   [Full Text] [Related]  

  • 19. Methotrexate treatment for refractory subacute cutaneous lupus erythematosus.
    Kuhn A; Specker C; Ruzicka T; Lehmann P
    J Am Acad Dermatol; 2002 Apr; 46(4):600-3. PubMed ID: 11907517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Update on Dermatologic Uses of Methotrexate.
    Shah RA; Nwannunu CE; Limmer AL; Patel RR; Mui UN; Tyring SK
    Skin Therapy Lett; 2019 Nov; 24(6):5-8. PubMed ID: 31801013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.